Breaking the upper limit of innovation: China’s dual-track regulatory framework for emerging biomedical innovations

The Innovation 2026 Open access

Read full text

Authors: Shawnholm Lau, Zhihong Wu, Xing Liu, Yi Zhang, Yanlin Cao

DOI: 10.1016/j.xinn.2026.101425

Cited by: 1

References: 2

Fields of Study & Subjects

Biomedical Ethics and Regulation Biotechnology and Related Fields Pharmaceutical Economics and Policy

References 2